Ország: Írország
Nyelv: angol
Forrás: HPRA (Health Products Regulatory Authority)
MOXIDECTIN
Pfizer Healthcare Ireland
QP54AB02
1 %w/v
Solution for Injection
Endectoparasiticides
Ovine
2012-03-23
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Cydectin 1% w/v Injectable Solution for Sheep 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Solution for Injection A clear to pale yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Sheep Each ml contains Moxidectin 10.00 mg Excipients Benzyl Alcohol 40.00 mg Butylated hydroxytoluene 2.50 mg Disodium edetate 0.27 mg QSP 1.000 ml For a full list of excipients, see section 6.1 IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 05/04/2012_ _CRN 7011266_ _page number: 1_ 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In sheep: Moxidectin is indicated for treatment of infections caused by moxidectin sensitive strains of: Gastro-intestinal nematodes: _. Haemonchus contortus_ _. Ostertagia (Teladorsagia) circumcincta _(including inhibited larvae) _. Trichostrongylus axei _(adults) _. Trichostrongylus colubriformis _(adults and L3) _. Nematodirus spathiger _(adults) _. Cooperia curticei (macmasteri) _(adults) _. Cooperia punctata _(adults) _. Gaigeria pachyscelis _(L3) _. Oesophagostomum columbianum _(L3) _. Chabertia ovina _(adults) Respiratory tract nematodes: _Dictyocaulus filaria _(adults) Larvae of Diptera: . _Oestrus ovis_: L1, L2, L3 Mange mites: _. Psoroptes ovis_ Moxidectin has a persistent effect of: _. _5 weeks against _Ostertagia circumcincta, Haemonchus contortus, Psoroptes ovis_ _. _4 weeks against _Gaigeria pachyscelis, Oesophagostomum columbianum_ _. _2 weeks against _Trichostrongylus colubriformis_ Trials have shown that moxidectin is effective against strains of _Haemonchus. contortus _resistant to benzimidazoles, ivermectin and doramectin. 4.3 CONTRAINDICATIONS See 4.8 and 4.11. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPE Olvassa el a teljes dokumentumot